New Journal Website is available at: http://www.journalonweb.com/rcm

Published by: Kowsar

Periprocedural Hemoglobin Changes and Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention

Keivan Alizadeh 1 , Saloomeh Pouralizadeh 1 , Sepideh Parchami-Ghazaee 1 , Abbas Zavvarehee 1 , Seifollah Abdi 1 , Farshad Shakerian 1 , Behshid Ghadrdoost 1 , Shiva Khaleghparast 1 , Negar Salehi 1 , Ata Firouzi 1 and Mohsen Maadani 1 , *
Authors Information
1 Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Research in Cardiovascular Medicine: August 10, 2013, 2 (3); 109-13
  • Published Online: July 31, 2013
  • Article Type: Research Article
  • Received: December 12, 2012
  • Revised: January 6, 2013
  • Accepted: February 17, 2013
  • DOI: 10.5812/cardiovascmed.9595

To Cite: Alizadeh K, Pouralizadeh S, Parchami-Ghazaee S, Zavvarehee A, Abdi S, et al. Periprocedural Hemoglobin Changes and Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention, Res Cardiovasc Med. 2013 ;2(3):109-13. doi: 10.5812/cardiovascmed.9595.

Abstract
Copyright: Copyright © 0, Research in Cardiovascular Medicine. .
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Ndrepepa G, Berger PB, Mehilli J, Seyfarth M, Neumann FJ, Schomig A, et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol. 2008; 51(7): 690-7[DOI][PubMed]
  • 2. Lansky AJ, Stone GW. Periprocedural myocardial infarction: prevalence, prognosis, and prevention. Circ Cardiovasc Interv. 2010; 3(6): 602-10[DOI][PubMed]
  • 3. Iijima R, Ndrepepa G, Mehilli J, Byrne RA, Schulz S, Neumann FJ, et al. Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention. Eur Heart J. 2009; 30(3): 290-6[DOI][PubMed]
  • 4. Lee KH, Lee SR, Kang KP, Kim HJ, Lee SH, Rhee KS, et al. Periprocedural hemoglobin drop and contrast-induced nephropathy in percutaneous coronary intervention patients. Korean Circ J. 2010; 40(2): 68-73[DOI][PubMed]
  • 5. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011; 58(24)-122[DOI][PubMed]
  • 6. Greer JP. Wintrobe’s Clinical Hematology. 2008;
  • 7. Lee PC, Kini AS, Ahsan C, Fisher E, Sharma SK. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2004; 44(3): 541-6[DOI][PubMed]
  • 8. McKechnie RS, Smith D, Montoye C, Kline-Rogers E, O'Donnell MJ, DeFranco AC, et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation. 2004; 110(3): 271-7[DOI][PubMed]
  • 9. Levy PS, Kim SJ, Eckel PK, Chavez R, Ismail EF, Gould SA, et al. Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis. Am J Physiol. 1993; 265(1 Pt 2)-9[PubMed]
  • 10. Carson Jeffrey L, Duff Amy, Poses Roy M, Berlin Jesse A, Spence Richard K, Trout Richard, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996; 348(9034): 1055
  • 11. Wahr JA. Myocardial ischaemia in anaemic patients. Br J Anaesth. 1998; 81 Suppl 1: 10-5[PubMed]
  • 12. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant. 2003; 7 Suppl 3: 86-8[PubMed]
  • 13. Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C, et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res. 2005; 96(1): 127-37[DOI][PubMed]
  • 14. Gagnon DR, Zhang TJ, Brand FN, Kannel WB. Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-up. Am Heart J. 1994; 127(3): 674-82[PubMed]
  • 15. Feit F, Voeltz MD, Attubato MJ, Lincoff AM, Chew DP, Bittl JA, et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol. 2007; 100(9): 1364-9[DOI][PubMed]
  • 16. Doyle BJ, Ting HH, Bell MR, Lennon RJ, Mathew V, Singh M, et al. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. JACC Cardiovasc Interv. 2008; 1(2): 202-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader